Cerbios-Pharma SA
↗Barbengo-Lugano, Switzerland
Cerbios-Pharma SA is a globally recognized Contract Development and Manufacturing Organization (CDMO) headquartered in Barbengo-Lugano, Switzerland, with nearly 50 years of experience in the pharmaceutical industry. The company specializes in the development and manufacturing of both chemical and biological Active Pharmaceutical Ingredients (APIs), with particular expertise in High Potency Active Pharmaceutical Ingredients (HPAPIs), recombinant proteins, and Antibody Drug Conjugates (ADCs). Cerbios operates two Swiss production facilities (Lugano and Couvet) that are regularly inspected by SwissMedic, FDA, and other global regulatory agencies. The company is a recognized leader in reduced folates for cancer treatments and has maintained proprietary expertise in probiotics (Enterococcus faecium SF68®) for gastrointestinal disorders for over 40 years.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Contract Manufacturing (CDMO), High-Potency APIs, Antibody-Drug Conjugates
SIZE & FINANCIALS
Employees:201-500
Revenue:$30-35M (Cerbios standalone)
Founded:1994
Ownership:subsidiary
Status:acquired
FUNDING
Investors:65 Equity Partners (approximately 40% post-acquisition, 2025), Braglia family (majority ownership retained post-acquisition)
PIPELINE
Stage:Preclinical|Clinical|Commercial
Lead Drug Stage:Commercial (as CDMO partner for multiple drugs)
Modalities:Small molecule, mAb (monoclonal antibody), ADC (Antibody-drug conjugate), Recombinant proteins, Probiotics, Cytotoxic payloads
Trial Phases:-
CORPORATE STRUCTURE
Parent Company:HAS Healthcare Advanced Synthesis SA
Acquired By:HAS Healthcare Advanced Synthesis SA (2025-05-07)
Key Partnerships:CMC Biologics - monoclonal antibody production for PROVEO, IDT Biologika - analytical services and supply chain management for PROVEO, Oncotec Pharma Produktion - aseptic fill and lyophilization for PROVEO ADCs, AGC Biologics - mAb production partner through PROVEO partnership
COMPETITION
Position:Leader
Competitors:Aavis Pharmaceuticals, InnoSer, Idifarma, Lonza, Samsung Biologics, Abzena, Charles River Laboratories, WuXi AppTec
LEADERSHIP
Key Executives:
Christian Suà - CEO & CFO
Claudio Pozzoli - Chief Operating Officer (COO)
Alberto Terraneo - Director of R&D
Denis Angioletti - Chief Commercial Officer (CCO)
Francesca Nembri - QA/DRA Director and Qualified Person (EU)
Anton van Troostenburg - Chairman
Rudolf Dudler - Vice-Chairman
Giada Burkhalter - Human Resources Director
Vitor Sousa - Director of Business Development
Kandid Oehen - Director Regulatory Affairs
Scientific Founders:CERNITIN SA (founded 1975), BIOFERMENT SA (founded 1976), SAPEC SA (founded 1979)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cerbios-Pharma SA. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.